We expect many companies face the challenge of scientifically invalid or dated dogma that impacts their business. Whether or not you are a manufacturer of pediatric vaccines facing concerns about autism debatable science becoming dogma can affect your business particularly if audiences are resistant to revisit their assumptions.
A good example of outdated or inaccurate dogma was described in the Wall Street Journal Currents column of October 21, 2009. Carl Bialik describes the often-quoted healthcare ranking of the United States at 37th in the world. The WHO study has been accepted as dogma by politicians and media alike. In fact, at a recent investor conference we heard Tom Daschle, the former senator from North Dakota, reference the ranking in a speech about U.S. healthcare reform. The only problem is that the ranking is dubious at best. According to the article, many of the inputs that generated the ranking were controversial or outdated. Others were unavailable and proxy data were used in their stead. The result is that the ranking study is probably worthless as a tool to understand U.S. healthcare. Despite this, the ranking is referenced often as fact.
What is a company to do when dogma that is either incorrect or based on inaccurate or irrelevant assumptions affects its business? It can be very difficult to change perceptions and one can be on the receiving end of hostile responses if the dogma is challenged (see “Shots in the Dark” by Shannon Brownlee and Jeanne Lenzer in the November, 2009 The Atlantic). Our advice is to first, craft a strong message with strong supporting points. Second, communicate this message to your target audiences. Third, be prepared with strong answers to difficult questions that you are likely to receive from skeptical members of your target audience. Fourth, be consistent and stick with the core of your message even as you refine it to respond to changing circumstances.